Drug Profile


Alternative Names: APD-209 - Acacia; Megestrol/formoterol

Latest Information Update: 07 Jan 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Acacia Pharma
  • Class Ethanolamines; Pregnadienes; Small molecules
  • Mechanism of Action Beta 2 adrenergic receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Cachexia

Most Recent Events

  • 07 Jan 2016 Acacia plans clinical trials for Cachexia (Acacia website; January 2016)
  • 01 Sep 2015 Phase II development for Cachexia is ongoing in the United Kingdom
  • 06 Dec 2011 Efficacy & adverse events data from a phase IIa trial in Cachexia released by Acacia Pharma
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top